PositiveDouble Blind Clinical Trial2022
Adjuvant palmitoylethanolamide therapy with risperidone improves negative symptoms in patients with schizophrenia: A randomized, double-blinded, placebo-controlled trial
Classification Results
AI Classification
PositiveFine-tuned Classification
Positive